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Criteria used to categorise proteins as allergens
for inclusion in allergenonline.org: a curated
database for risk assessment
Richard Goodman1*, Ronald van Ree2, Stefan Vieths3, Fatima Ferreira4, Motohiro Ebisawa5, Hugh A Sampson6,
Joseph Baumert7, John Wise7, Steve L Taylor7
From 5th International Symposium on Molecular Allergology (ISMA 2013)
Vienna, Austria. 6-7 December 2013
Background
New proteins introduced in foods through genetic engi-
neering or processing are often evaluated for potential
risks of eliciting food allergy (Codex, 2003). The primary
risk is the transfer of an allergen or a protein nearly identi-
cal to an allergen and capable of causing IgE mediated
cross-reactions into a new food source. The AllergenOn-
line.org database was developed to provide a curated set of
allergenic sequences for bioinformatics comparisons to
identify proteins that should be tested further (e.g. serum
IgE binding). Curation is necessary as the scientific litera-
ture and general sequence databases include thousands of
proteins labeled as allergens that lack proof of allergenic
activity.
Methods
In 2006 we developed guidelines for reviewing and classi-
fying candidate proteins as “allergens”, “putative allergens”
and those with “insufficient evidence” of causing IgE
mediated allergic reactions in humans. Airway, contact,
venom, salivary and food allergens are included. Criteria
were developed for judging allergic subjects; allergen
sources; protein characteristics, sequences; allergenic activ-
ity and IgE binding. Candidate allergens and peer reviewed
publications are identified from the NCBI Protein and
PubMed databases using keywords for review by our
panel. Data, evaluations and decisions are stored in an
achieved data management system during an annual
update process. Access and FASTA searches are free,
anonymous and unrecorded.
Results
We evaluate: descriptions of allergic and control sub-
jects (numbers and ages; types of reactions); symptom
onset; route of exposure (contact, ingestion, inhalation
or injection); diagnostic methods (history, skin prick test
or other challenge, specific IgE, basophil activation). We
consider allergen source information (taxonomy, tissue
source, maturity or processing); evidence the protein is
present in the test material; protein characterization and
source (purified vs. extract, native vs. recombinant);
sequence and methods (cDNA or protein sequence);
molecular mass and glycosylation status. Specific IgE
measurements should include standards, controls, details
of critical reagents and scoring criteria. Tests should
purified proteins as well as extracts to demonstrate rele-
vance. Four examples are presented.
Conclusions
Data quality and evidence of the importance of indivi-
dual allergens varies markedly while the rate of publica-
tion of poorly described allergens and sequences is
rising rapid.
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